Epidemiology and reporting characteristics of preclinical systematic reviews in PLoS Biology7 June 2021
Kim Wever, researcher of the department of Health Evidence and an international team published the article 'Epidemiology and reporting characteristics of preclinical systematic reviews' in PLoS Biology.
Millions of euros for study of laser treatment for glioblastoma2 April 2021
A research group from Radboudumc and UMC Utrecht is to investigate laser treatment of a rare brain tumor, glioblastoma. 3.9 million euros has been made available for the research by Zorginstituut Nederland and ZonMw, under the auspices of the Subsidy Scheme for Promising Care.
Differences in the placental disposition of TNF inhibitors uncovered19 March 2020
In Clinical Pharmacology and Therapeutics, researchers from the Depts. of Pharmacology and Toxicology, Obstetrics and Gynecology, and Health Evidence, in collaboration with Sanquin Diagnostic Services, investigated the placental handling of the TNF inhibitors infliximab and etanercept.
Plugging the gap ZonMw/Health Holland grant3 March 2020
RIMLS en RIHS researchers Willeke Daamen, Frank Vandenbussche, Joris van Drongelen, Toin van Kuppevelt and Janneke Grutters have been granted 1.3 million euro for the development and evaluation of a new technology to prevent premature rupture of fetal membranes (iPPROM).
Citizen forum on coverage decisions in the Dutch health insurance benefit package3 February 2020
In this article published in Value in Health RIHS researchers Leon Bijlmakers, Maarten Jansen and Rob Baltussen describe the preferences and dilemmas expressed by Dutch citizens in eight case studies, all of which require trade-offs between criteria that cannot all be satisfied at the same time.
Awarded KWF grants for Radboudumc researchers18 December 2019
KWF is investing 2.7 million euros in five different studies at Radboudumc. The awards are part of the new round of funding by DCS, in which over 34 million euros will be granted to Dutch cancer research. We congratulate our researchers with this funding and wish them success with their great work.
Merel Ritskes-Hoitinga has been appointed honorary Skou professor at Aarhus University17 October 2019
Merel Ritskes-Hoitinga has been appointed honorary Skou Professor at the Dept. of Clinical Medicine, at Aarhus University. The aim is to introduce new perspectives to teaching, strengthen relations with leading research units abroad and establish joint research projects and funding applications.
Social media posts on medication use during pregnancy often incorrect23 August 2019
Dutch social media regularly post about the safety of medicines for pregnant women. Many pregnant women use these posts as a source of information. A new analysis shows, however, that information found on social media about the risk of medication use often does not correspond with guidelines.
European Commission Initiative on Breast Cancer (ECIBC) Guidelines13 August 2019
In Annals of internal medicine Mireille Broeders and colleagues from the ECIBC Guidelines Development Group described the methods used to develop person-centered evidence-based recommendations for screening and diagnosis of breast cancer.
Ingenious solution, but what was the problem?29 May 2019
In Value in Health Anouck Kluytmans, Marcia Tummers, Gert Jan van der Wilt and Janneke Grutters found, using a mixed methods approach, that although a recently developed medical technology was deemed ingenious by stakeholders, there was no underlying problem it could solve in its intended context.
How do we keep new technology affordable to improve the lives of people?16 May 2019
Improving healthcare by means of new technological developments? We need to change the entire approach for evaluating the true impact , says Maroeska Rovers. By bringing together all stakeholders from the beginning, millions of euros can be saved.
Association of gestational weight gain with adverse maternal and infant outcomes13 May 2019
An individual participant meta-analysis published in JAMA showed that pregnancy BMI is related stronger to maternal and infant complications than to gestational weight gain. The PRIDE Study, with coauthors Marleen van Gelder and Nel Roeleveld, was one of the participating cohorts.
Research into drugs for treating rare diseases can be more efficient and patient-oriented18 December 2018
To assess whether a drug is an effective treatment for a rare disease, large-scale research with Randomized Controlled Trials may not be necessary in all situations, say researchers from the departments of Neurology and Health Evidence in the Journal of the American Medical Association (JAMA).
Making choices in healthcare is difficult but citizens will show politics the way22 June 2018
Well-informed citizens are not just aware of the financial necessity of making choices in healthcare, they are also prepared to make these choices. They do so by providing concrete criteria and examples, which serve as guidelines for politicians.
The National Healthcare Institute (ZIN) provides insight in the displacement of healthcare25 April 2018
Displacement of care is difficult to assess. On behalf of the National Healthcare Institute, a consortium led by the Radboudumc has therefore carried out research into displacement of care in Dutch healthcare.
First lustrum student visit WHO & UNAIDS in Geneva7 February 2018
The students got a firsthand experience of what it is like to be in the Global Health capital of the world, to get a better understanding of the broader context of global health policy and the implementation of international health guidelines.
Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies31 January 2018
In PLoS ONE Carlijn Hooijmans and colleagues describe how the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) approach, could be used to rate the certainty in the evidence of preclinical animal studies in the context of therapeutic interventions.